ArticleCardiology and therapy2026

Survival in a Contemporary, Real-World, Matched Cohort of Patients with Transthyretin Amyloid Cardiomyopathy Treated vs Not Treated with Tafamidis.

Fabian Aus dem Siepen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.